A phospholipid derivative of cytosine arabinoside and its conversion to phosphatidylinositol by animal tissue
- PMID: 191910
- DOI: 10.1126/science.191910
A phospholipid derivative of cytosine arabinoside and its conversion to phosphatidylinositol by animal tissue
Abstract
We have synthesized an analog (ara-CDP-DL-dipalmitin) of cytidine diphosphate diglyceride (CDP-diglyceride) in which the antitumor drug, cytosine arabinoside, is substituted for the cytidine moiety. Enzymes in rat and human liver convert this analog to phosphatidylinositol, thereby releasing cytosine arabinoside-5'-monophosphate, an obligatory intermediate in the activation of cytosine arabinoside. Unlike cytidine diphosphate diglyceride, however, ara-CDP-DL-diapalmitin is not an efficient substrate for phosphatidylglycerophosphate synthesis in liver or phosphatidylserine in Escherichia coli. The antitumor activity of ara-CDP-DL-dipalmitin in mice bearing L5178Y leukemia is described.
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        